Source: International Congress 2016 – Novel strategies on COPD and asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nausherwan Burki (Farmington, United States of America), Nausherwan Burki, Marsden Granger, Debapriya Datta. LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD. Eur Respir J 2016; 48: Suppl. 60, 4836

Member's Comments

No comment yet.

Related content which might interest you: Pharmacologic bronchodilation response to salbutamol in COPD patients Source: International Congress 2014 – Predictors Year: 2014 LATE-BREAKING ABSTRACT: A phase 2a study of benralizumab in adults with COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 BioPhysical bronchodilator: A new class of respiratory drug Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 miRNA-145 & SMAD3 expression in patients with COPD Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Importance of surface cooling during targeted lung denervation for COPD Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Targeted lung denervation in the healthy sheep model - A potential treatment for COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Bronchial thermoplasty as an option for severe asthma patients - our experiences and retrospective evaluation Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema Year: 2014 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Mitochondrial membrane potential in the airway and skeletal muscle compartments of smokers with and without COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 The anti-proliferative effect of hydrogen sulfide upon human airway smooth muscle in COPD Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Exaggerated airway narrowing is related to increased airway smooth muscle mass in bronchial segments from subjects with a history of asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 The critical role of bronchial smooth muscle remodeling in non-severe asthma Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015